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EFFICACY OF CHLORHEXIDINE DRESSINGS FOR THE PREVENTION 
OF CATHETER ENTRY SITE INFECTIONS: RESULTS FROM A PROSPEC- 
TIVE RANDOMISED TRIAL IN HAEMATOLOGY PATIENTS RECEIVING 
CHEMOTHERAPY 
Sanders, 7.; Chambers, S.; R~th, S.; Pattoll, 14'~ Hae~n~tology, 
Christchm'ch Hospital, Christchurch, New Zealamt. 
Ainu Exit site infections in tunnelled central catheters are a fre- 
quent source of morbidity in neutropenic patients. These usually 
require antibiotic therapy with the attendant costs of administra- 
tion, promotion of antibiotic resistance and adverse effects. This 
study investigates the question of whether chlorhexidine dressings 
reduce the rates of such infections. Methods: We have conducted 
a prospective randomised trial of these dressings (Biopatch) 
against he current British standard of care. The standard arm was 
a dry dressing until the site is dry and free from ooze and then no 
dressing. An infected site was defined as reddening, pain and ten- 
derness at the exit site sufficient o cause the attending clinician to 
prescribe ant imicrobial  therapy, i14 patients treated with 
chemotherapy were randomised to one of the two treatment arms 
and the same dressings were used for the duration of catheter life. 
Double lmnen Hickman catheters were used in 106(92%). 55 
patients received standard dressings and 59 chlorhexidine dress- 
ings. Results: 93% of patients became neutropenic. (neutrophil 
count < 1.0x 109/I.) The distribution of age, sex, primary diagnosis, 
number of treatment episodes and duration of neutropenia were 
similar between the two groups. The primary endpoint was e~t 
site infection, which occurred in 36.6% patients with the standard 
dressing and 5.08% with the biopatch dressing. Combined exit 
site, tunnel and luminal infections occurred in 9/55 16.3% and 
2/59 3.3% respectively. There was no difference between the two 
groups in the reasons for catheter emoval, bacteraemic episodes 
or catheter life. Conclusions: Exit site infections were a common 
problem in neutropenic patients treated in the standard manner 
but were signif icantly reduced with chlorhexidine dressings 
(Biopatch). This suggests that these dressings hould be strongly 
considered in routine management of neutropenic episodes. 
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VALIDATION OF THE NURSING DIAGNOSIS ANXIETY AS EXPERIENCED 
BY ADULT BONE MARROW TRANSPLANT PATIENTS FROM THE PER- 
SPECTIVE OF THE PATIENT, SIGNIFICANT OTHER AND NURSE 
Yom~g, L.K.I; Pol~in, if.e; Todd, S.'; Sinl, m~cak, S.L. ~- 1. Na'rsi1~g, 
MSOE, 3/lilwallkee, ~VI; 2. Froedtert Memorial Lnthera~ Hospital, 
34il'waukee, ~fq. 
The purpose of this study was to validate the nursing diagnosis 
anxiety, as experienced by adult bone marrow transplant patients. 
A descriptive, longitudinal design was chosen, data from patients, 
significant others and nurses were collected on the first day of 
conditioning, twenty-five days later, and one hundred days post 
transplant. Patients who experienced autologous r allogeneic 
transplants were included in the study. Findings included a signiif- 
icant differnce between the stai anxiety scores. The stai anxiety, 
scores revealed moderate anxiety at time one, low anxiety at time 
two and moderate anxiety at time three. A Significant positive cor- 
relation was found between the patient stai scores and graphic 
scores and the stai scores and DCT scores at time one and two, 
and between the DCT scores and graphic scores at time two. A 
significant positive correlation was found between the patient dct 
scores and significant other dct scores at time one and two. 18 
critical and supporting defining charcteristics were iidentified by 
the patient, 20 identified by the signicant other and 9 by the 
nurse. Significant others were found to be a valid resource in iden~ 
tification of the paients' level of anxiety, as welI as the defining 
characteristics of anxiety, a tool that consists of the critical and 
supporting defining characteristics of anxiety, as experienced by 
bone marrow transplant patients, is recommended for further 
deveh)pment and testing. Use of a visual analog scale to assess 
anxiety in clinical environments hould be considered. (Key 
Words: anxiety, bone morrow transplantation, nursing diagnosis) 
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THE TANDEM AUTOLOGOUS AND MATCHED RELATED NONMYE- 
LOABLATIVE HSCT PATIENT: WHAT'S DIFFERENT? 
Anderso~l, LA. Seattle Cancer Cave Allim~ce, Seattle, H"~q. 
The patient eligible for the tandem transplant typically presents 
in a more compromised state of health due to the process of 
recovering from mobilization, debulking chemotherapy, hemopo- 
etic stem cells storage, and autologous transplantation. There are 
key differences frona the ablative transplant in the appropriate 
pat ient and caregiver education regarding the evaluation and 
work-up. In many treatment centers the pre and post transplant 
management is connnonly conducted strictly in the out patient 
arena. This necessitates compressed time for patient and caregiver 
education, coordination of clinics and routine testing. Encourag- 
ing the use of existing and complex support systems to report 
complications and or concerns is essential. Some of the Clinical 
issues which will be discussed include: The patient will likely have 
a Short Double Lmnen central ine, and be taking warfiarin. This 
needs to be discontinued when platelet count < 50K. Warfarin's 
efficacy is affected with the addition of Cyclosporine (CSP) Com~ 
bined immunosuppression with the use of both Mycophenolate 
Mofeti l  (MMF) and CSP up to 56 days can be challenging to 
those who find it difficult to swallow pills. Unlike thc standard 
aIlogenic transplant, serum CSP levels are kept in the 500 - 600 
ng/mL range. FaciaI flushing, burning or tender sldn on hands 
and or feet may not resolve while these levels are maintained nr 
ing the first 30 days of transplant. Reassurance to both the care- 
giver and patient hat this effect is normal and expected, and not 
an indication that there is 'something wrong'. Even those patients 
with prior compromised renal fimction will be maintained with 
potentially renal to,'dc serum levels of CSP. This *nay develop into 
kidney failure necessitating dialysis. At the time of the discharge 
work-up, usually 80 to 100 days post transplant, it is not unusual 
for the patient o be off" immunosuppressive drugs. This places the 
patient at a greater isk of developing acute graft versus host dis- 
ease (GVHD) in a setting that may not be familiar with diagnos- 
ing GVHD and re- implementing immunosuppressive therapy. 
This paper will illuminate the necessity and details involved in 
caring for patients and caregivers who are experiencing a tandem 
transplant. 
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QUALITY IMPROVEMENT: INTERDISCIPLINARY TEAMS START YOUR 
BINDERS! 
Sorensen, S.L.; Rhodes, B.; Samamego, C.; H(alker, ft.; Peck, N.; Ador- 
netto, D. Apheresis, MDdmteTson Cancer Center, ltonston, T~. 
Challenged with developing a Quality Improvement Plan in the 
Apheresis area of the Blood and Marrow Transplantation Pro- 
gram, the initial step was to discover what was presently being 
done. The Apheresis nurses identified two areas of concern, the 
patient satisfaction survey and chart audits. The patient satisfiac- 
tion survey was a joint survey distributed to both outpatient Blood 
and Marrow Transplant patients and those in Apheresis. The 
nursing staff re-wrote the survey to obtain information relevant o 
the Apheresis refit. The survey was distributed montly and the 
results were trended and discussed at staff meetings. The results 
were graphed and displayed on a "story board" using the institu- 
tional quality improvement process of "Plan, Do, Check, Act". 
This format allowed for an on-going process of identi .lying and 
resolving problems. Chart audits were re instituted using a differ- 
ent slant. Apberesis charts would be audited as opposed to the 
patient's entire medical record, giving a clearer picture of the con- 
tent and completeness of the documentation of the staff. Criteria 
were set for auditing donor charts; the goal was to audit 100% of 
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